134 related articles for article (PubMed ID: 28978610)
1. Does quality of life outweigh the cardiovascular risks of stimulant medication in a child with ADHD and hypertrophic cardiomyopathy?
Senderey E; Sousa J; Stavitsky M
BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 28978610
[TBL] [Abstract][Full Text] [Related]
2. Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?
Iyer S; Kumar M; Reiff MI; Stein MT
J Dev Behav Pediatr; 2017; 38 Suppl 1():S60-S62. PubMed ID: 28141724
[TBL] [Abstract][Full Text] [Related]
3. Inattentive Attention-Deficit/Hyperactivity Disorder, Stimulant Medication, and Weight Loss in a 15-Year-Old Girl: Are We Enabling the Development of an Eating Disorder?
Iyer S; Kumar M; Reiff MI; Stein MT
J Dev Behav Pediatr; 2015 Sep; 36(7):549-51. PubMed ID: 26348973
[TBL] [Abstract][Full Text] [Related]
4. Stimulant medication for the child with attention-deficit/hyperactivity disorder.
Bennett FC; Brown RT; Craver J; Anderson D
Pediatr Clin North Am; 1999 Oct; 46(5):929-44, vii. PubMed ID: 10570697
[TBL] [Abstract][Full Text] [Related]
5. [Supervised off-label prescribing of methylphenidate in adult ADHD].
Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
[TBL] [Abstract][Full Text] [Related]
6. Safety of stimulant treatment in attention deficit hyperactivity disorder: part II.
Merkel RL
Expert Opin Drug Saf; 2010 Nov; 9(6):917-35. PubMed ID: 20615078
[TBL] [Abstract][Full Text] [Related]
7. Factors influencing parental decision making about stimulant treatment for attention-deficit/hyperactivity disorder.
Ahmed R; McCaffery KJ; Aslani P
J Child Adolesc Psychopharmacol; 2013 Apr; 23(3):163-78. PubMed ID: 23560602
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular Effects of Stimulant and Non-Stimulant Medication for Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of Trials of Methylphenidate, Amphetamines and Atomoxetine.
Hennissen L; Bakker MJ; Banaschewski T; Carucci S; Coghill D; Danckaerts M; Dittmann RW; Hollis C; Kovshoff H; McCarthy S; Nagy P; Sonuga-Barke E; Wong IC; Zuddas A; Rosenthal E; Buitelaar JK;
CNS Drugs; 2017 Mar; 31(3):199-215. PubMed ID: 28236285
[TBL] [Abstract][Full Text] [Related]
9. Can stimulant rebound mimic pediatric bipolar disorder?
Sarampote CS; Efron LA; Robb AS; Pearl PL; Stein MA
J Child Adolesc Psychopharmacol; 2002; 12(1):63-7. PubMed ID: 12014597
[TBL] [Abstract][Full Text] [Related]
10. Emergence of tics in children with attention deficit hyperactivity disorder treated with stimulant medications.
Varley CK; Vincent J; Varley P; Calderon R
Compr Psychiatry; 2001; 42(3):228-33. PubMed ID: 11349243
[TBL] [Abstract][Full Text] [Related]
11. Attention deficit hyperactivity disorder medications in children with heart disease.
Berger S
Curr Opin Pediatr; 2016 Oct; 28(5):607-12. PubMed ID: 27261563
[TBL] [Abstract][Full Text] [Related]
12. Universal precautions to reduce stimulant misuse in treating adult ADHD.
Modesto-Lowe V; Chaplin M; Sinha S; Woodard K
Cleve Clin J Med; 2015 Aug; 82(8):506-12. PubMed ID: 26270429
[TBL] [Abstract][Full Text] [Related]
13. Adherence to stimulants in adult ADHD.
O'Callaghan P
Atten Defic Hyperact Disord; 2014 Jun; 6(2):111-20. PubMed ID: 24604104
[TBL] [Abstract][Full Text] [Related]
14. Medication therapy for attention deficit/hyperactivity disorder is associated with lower risk of fracture: a retrospective cohort study.
Perry BA; Archer KR; Song Y; Ma Y; Green JK; Elefteriou F; Dahir KM
Osteoporos Int; 2016 Jul; 27(7):2223-2227. PubMed ID: 26928186
[TBL] [Abstract][Full Text] [Related]
15. Parent-Reported Improvements in Family Functioning in a Randomized Controlled Trial of Lisdexamfetamine for Treatment of Parental Attention-Deficit/Hyperactivity Disorder.
Babinski DE; Waxmonsky JG; Waschbusch DA; Humphery H; Pelham WE
J Child Adolesc Psychopharmacol; 2017 Apr; 27(3):250-257. PubMed ID: 27991835
[TBL] [Abstract][Full Text] [Related]
16. Stimulant therapy in children with attention-deficit/hyperactivity disorder and concomitant long QT syndrome: A safe combination?
Rohatgi RK; Bos JM; Ackerman MJ
Heart Rhythm; 2015 Aug; 12(8):1807-12. PubMed ID: 25956966
[TBL] [Abstract][Full Text] [Related]
17. Informed consent and stimulant medication: adolescents' and parents' ability to understand information about benefits and risks of stimulant medication for the treatment of attention-deficit/hyperactivity disorder.
Schachter D; Tharmalingam S; Kleinman I
J Child Adolesc Psychopharmacol; 2011 Apr; 21(2):139-48. PubMed ID: 21504355
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular risk of stimulant treatment in pediatric attention-deficit/hyperactivity disorder: update and clinical recommendations.
Hammerness PG; Perrin JM; Shelley-Abrahamson R; Wilens TE
J Am Acad Child Adolesc Psychiatry; 2011 Oct; 50(10):978-90. PubMed ID: 21961773
[TBL] [Abstract][Full Text] [Related]
19. Management of stimulant medications in children with attention-deficit/hyperactivity disorder.
Adesman AR; Morgan AM
Pediatr Clin North Am; 1999 Oct; 46(5):945-63, vii-viii. PubMed ID: 10570698
[TBL] [Abstract][Full Text] [Related]
20. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
